Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer

2020 ◽  
Vol 30 (12) ◽  
pp. 1350-1353
Author(s):  
Hwee Ting Vanessa Tey ◽  
Shuo Min Jonathan Foo ◽  
Sau Shung Fong ◽  
Choon Seng Chong
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Three Dimensional ◽  
Transanal Total Mesorectal Excision ◽  
Two Dimensional ◽  
Mesorectal Excision ◽  
Short Term ◽  
Oncological Outcomes

scholarly journals Robotic Total Mesorectal Excision for Rectal Cancer: Short-Term Oncological Outcomes of Initial 178 Cases

2020 ◽  
Vol 11 (4) ◽  
pp. 653-661
Author(s):  
C. Ramachandra ◽  
Pavan Sugoor ◽  
Uday Karjol ◽  
Ravi Arjunan ◽  
Syed Altaf ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Minimally Invasive ◽  
Total Mesorectal Excision ◽  
Resection Margin ◽  
Da Vinci ◽  
Rectal Resection ◽  
Mesorectal Excision ◽  
Short Term ◽  
Oncological Outcomes ◽  
Duration Of Surgery

AbstractEmerging techniques in minimally invasive rectal resection include robotic total mesorectal excision (R-TME). The Da Vinci Surgical System offers precise dissection in narrow and deep confined spaces and is gaining increasing acceptance during recent times. The aim of this study is to analyse our initial experience of R-TME with Da Vinci Xi platform in terms of perioperative and oncological outcomes in the context of data from recently published randomised ROLARR trial amongst minimally invasive novice surgeons. Patients who underwent R-TME or tumour specific mesorectal excision for rectal cancer between May 2016 and November 2019 were identified from a prospectively maintained single institution colorectal database. Demographic, clinical-pathological and short-term oncological outcomes were analysed. Of the 178 patients, 117 (65.7%) and 31 (17.4%) patients had lower and mid third rectal cancer. Most of the tumours were locally advanced, cT3–T4: 138 (77.5%). One hundred/178 (56.2%) underwent sphincter preserving TME. Eighty-seven (48.8%) were grade II adenocarcinoma. Nonmucinous adenocarcinoma was the predominant histology, 138 (78.4%). One hundred one cases (56.7%) were pT3. The mean number of lymph node yield was 13 ± 5. Distal resection margin and circumferential resection margin were positive in 2 (1.12%), 12 cases (6.74%) respectively. Eleven cases (6.7%) had to be converted to open TME. Mean blood loss and duration of surgery was 170 ± 60 ml and 286 ± 45 min respectively. Five percent cases had an anastomotic leak. Grade IIIa–IIIb Clavien Dindo (CD) morbidity score was reported to be in 12 (6.75%) and 10 (5.61%) cases. Median length of hospitalisation was 7 days (range 4–14 days). Perioperative and pathologic outcomes following robotic rectal resection is associated with good short-term oncological outcomes and is safe, effective, and reproducible by a minimally invasive novice surgeon.

Transanal Total Mesorectal Excision (TaTME): A Literature Review

2020 ◽  
Vol 13 (1) ◽  
pp. 3-7
Author(s):  
Martin P. Karamanliev ◽  
Dobromir D. Dimitrov
Keyword(s):  
Rectal Cancer ◽  
Literature Review ◽  
Total Mesorectal Excision ◽  
Randomized Clinical Trials ◽  
Perioperative Complications ◽  
Transanal Total Mesorectal Excision ◽  
Mesorectal Excision ◽  
Oncological Outcomes ◽  
Golden Standard ◽  
Meta Analyses

Summary Total mesorectal excision (TME) has become the golden standard for treating rectal cancer since Heald introduced it [1]. Transanal total mesorectal excision (taTME) is an innovative surgical method for rectal cancer. A nonsystematic literature review on the articles on taTME in the PubMed and Scopus database was performed. ‘TaTME’ and ‘transanal total mesorectal excision’ keywords were used. The search was restricted to articles in English on more than 25 patients analyzed and followed-up. Fourteen articles were identified, most of them from Europe and China. Of these, eight were original studies, and six were systematic reviews and meta-analyses. TaTME is safe and efficient in experienced hands. It could be superior to laparoscopic total mesorectal excision (laTME) concerning perioperative complications. Its advantages in oncological outcomes over laTME are to be proven in structured randomized clinical trials (RCTs).

Sign in / Sign up

Export Citation Format

Share Document